Supernova 2

Supernova Invest, established in 1999, is a Paris-based private equity and venture capital firm with additional offices in Grenoble. It manages a €800m fund, Supernova 2, founded in 2017. The firm specializes in early-stage investments, focusing on deep technology companies across sectors such as healthcare, industry 4.0, energy & environment, and digital technologies. It provides patient capital and expertise to support high-growth startups, with a track record of successful exits through IPOs and M&As. Supernova Invest partners with CEA Investissement to offer startups access to the CEA network and services.

Cécile Benet

Investment Director

Lucille Benoît

Analyst

Alexandre Biau

Investment Director

Alexandre Biau

Investment Director

Damien Bretegnier

Investment Director

Carole Cazassus

Investment Director

Pascal-André Chenal

Investment Manager

Alexandre Cordier

Analyst

Julien Cristiani

Partner

Arthur Falinower

Analyst

Marine Glon

Investment Director

Celia Hart

Partner

Claude-Sebastien Lerbourg

Investment Director

Etienne Moreau

Partner

Arthur Puig

Associate

Romain Sautrau

Investment Director

Remi Spagnol

Investment Director

Pierre-Emmanuel Struyven

President and Managing Partner

Michaël Thomas

Partner

Michael Thomas

Investment Director

Nicolas Topuz

Analyst

Gregoire Viot

CFO

Claude-Sebastien Lerbourg

Investment Director

Pascal-andré Chenal

Investment Director

82 past transactions

mirSense

Series A in 2025
mirSense SA is a developer and manufacturer of advanced Quantum Cascade Lasers (QCL) and QCL-based spectrometer modules, headquartered in Palaiseau, France. Established in 2015, the company specializes in ultra-compact gas sensors aimed at controlling gas emissions and analyzing biological samples. Its product lineup includes single mode lasers for high spectral purity, semiconductor solutions for broadband tuning, and spectrometer modules tailored for gas analyzer manufacturers. Additionally, mirSense produces power lasers for defense and security applications. The technology developed by mirSense is designed to achieve low detection levels, enhancing indoor and outdoor air quality, reducing greenhouse gas emissions, and improving the accuracy of medical treatments. By providing affordable high-performance laser spectroscopy alternatives, mirSense supports various industries in their pursuit of sustainability and safety.

Galam Robotics

Series A in 2025
Galam Robotics specializes in modular robotic solutions aimed at enhancing logistics and storage processes. The company develops innovative technology that increases productivity and efficiency in urban logistics and trade environments. By transforming storage capabilities in constrained spaces, Galam Robotics enables clients to optimize their storage capacity while maximizing input and output flows. This approach allows businesses to streamline their operations and improve overall performance in logistics and inventory management.

Fyteko

Series B in 2025
Fyteko is an agtech company founded in 2014 and based in Brussels, Belgium. The company focuses on the development and production of advanced plant biostimulants designed to enhance crop resistance to abiotic stressors, such as drought and salinity. By utilizing bio-based technologies, Fyteko aims to improve agricultural productivity and quality while addressing the environmental impacts of farming practices. Their innovative biomolecule solutions support farmers in cultivating healthier crops, ultimately contributing to sustainable agricultural practices.

Enduro Genetics

Series A in 2025
Enduro Genetics is a technology provider that specializes in enhancing large-scale fermentations through its proprietary synthetic biology technology. The company focuses on improving the performance of fermentation processes by developing a genetic plugin technology that is free of antibiotic resistance genes. This innovation allows for higher yields by enriching spontaneous high producers within the fermentation population, facilitating the production of complex or cellular inhibit products by addressing strain instability. By maximizing the performance of cells derived from production strains, Enduro aims to bolster the competitiveness of both current and future green bioproduction initiatives.

Alice & Bob

Series B in 2025
Alice & Bob is a Paris-based company founded in 2020 that specializes in the manufacture of universal, error-free quantum computers. The company's innovative technology features self-correcting superconducting quantum bits, which allow for fault-tolerant quantum computing. This capability enables the execution of any quantum algorithm, thereby assisting industries and researchers in addressing complex challenges across various fields. By focusing on developing advanced quantum computing solutions, Alice & Bob aims to facilitate breakthroughs in solving significant problems in quantum research and industry applications.

Capra Robotics

Seed Round in 2025
Capra Robotics is a research engineering company that specializes in the development of mobile robots aimed at enhancing outdoor mobility. The company has patented a platform for electric mobility devices designed for both indoor and outdoor use. These robots are characterized by their maneuverability, user-friendliness, and portability, making them suitable for individuals who are inactive or physically challenged. Capra Robotics aims to improve the quality of life for these users by providing them with a practical solution for navigating various terrains.

Loft Orbital

Series C in 2025
Loft Orbital Solutions Inc. is a company based in San Francisco, California, that provides comprehensive services for the deployment and operation of customer payloads in space. Established in 2017, Loft Orbital specializes in operating microsatellites and offers an end-to-end solution that includes satellite platform integration, launch booking, and operational management. The company simplifies the satellite deployment process by utilizing a standardized satellite bus and a suite of software tools, thereby reducing costs and accelerating the timeline to orbit. Additionally, Loft Orbital addresses financial and regulatory challenges by providing solutions for licensing, insurance, and financing, allowing customers to concentrate on their mission objectives rather than the technical complexities of satellite engineering.

ANYbotics

Series B in 2024
ANYbotics AG is a Swiss robotics company founded in 2016 and based in Zurich. The company specializes in developing autonomous legged robots designed for industrial applications, particularly in hazardous and complex environments. These robots feature advanced capabilities such as docking stations, robust waterproof designs, and various sensing technologies. They are equipped to perform tasks like asset monitoring, equipment health checks, and event detection, thereby enhancing productivity and safety for workers in sectors such as oil and gas, power, energy, mining, chemicals, transportation, and construction. With a team of over 100 employees, ANYbotics aims to support industrial facilities in their inspection needs, promoting more sustainable operations through intelligent robotic solutions.

Dessia

Venture Round in 2024
DessIA is a developer of augmented engineering software that leverages artificial intelligence to streamline product development. The company's platform assists engineers and architects by automating tasks in the early stages of design, generating numerous architectural options, and identifying optimal configurations that align with sustainability and profitability goals. By addressing complex engineering challenges, DessIA enables automotive and mechanical engineers to enhance their efficiency and explore innovative solutions, ultimately reducing lead times and increasing profit margins.

Discure

Series A in 2024
Discure Technologies is focused on creating a minimally invasive, implantable bioelectronic device aimed at treating degenerative disc disease (DDD). This innovative device employs a novel bioelectric technique that addresses the root cause of DDD, allowing physicians to alleviate pain and restore normal disc function in patients. By promoting healing of the affected discs, Discure seeks to improve the quality of life for individuals suffering from this condition.

Wattalps

Series A in 2024
Wattalps specializes in developing lithium power systems aimed at providing affordable battery solutions for small and medium series applications. The company's products prioritize passive safety, cooling efficiency, long life, and cell protection, facilitating the integration of these systems into vehicles and charging stations. With a focus on creating standard and modular designs, Wattalps aims to simplify installation processes, making them both fast and cost-effective. By advancing these technologies, the company contributes to the broader adoption of electric vehicles and sustainable transportation solutions.

Micropep

Series B in 2024
Micropep Technologies is an agricultural biotechnology firm based in Toulouse, France, founded in 2016. The company specializes in developing non-GMO bioherbicides and biostimulants through its proprietary miPEP technology, which utilizes naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep's approach allows for the temporary control of gene expression without altering the plant's DNA, focusing on optimizing various stages of plant development, including germination, flowering, growth, and weed control. By leveraging these innovative solutions, Micropep aims to improve agricultural yields and support sustainable farming practices.

UroMems

Series C in 2024
UroMems is a company dedicated to addressing specific clinical needs related to patient care, particularly in the area of urology. It develops implantable medical devices aimed at enhancing existing surgical treatments, thereby improving patient outcomes and reducing side effects. By focusing on innovative solutions, UroMems seeks to ensure that more patients can access effective treatments quickly, ultimately aiming to enhance their quality of life. The company is committed to the design, development, and commercialization of these active implantable devices, which reflect a deep understanding of the challenges faced by patients.

Seederal

Series A in 2024
Seederal Technologies is a manufacturer specializing in agriculture, construction, and mining machinery, with a focus on innovative medium-power electric tractors. The company designs tractors that generate 160 horsepower using electric motors, aiming to minimize the environmental impact associated with traditional agricultural equipment. By reducing the cost of ownership for farmers, Seederal Technologies supports the transition to electric machinery in agriculture, providing an alternative that matches the performance of conventional tractors while promoting sustainability.

Diabeloop

Venture Round in 2024
Diabeloop is a medical device company based in Grenoble, France, focused on innovating diabetes treatment through advanced technology. Founded in 2015, the company specializes in developing an AI-based closed-loop system that automates insulin delivery for individuals with type 1 diabetes. This system includes a blood sugar monitoring device that combines a glucose sensor, an insulin pump, and a smartphone application featuring an embedded algorithm. By continuously measuring glucose levels and delivering the appropriate insulin dosage, Diabeloop aims to reduce the mental burden on patients, allowing them to manage their condition more effectively and live their lives with greater ease.

Wise Integration

Series B in 2024
Developer of generative adversarial network integrated circuits and digital control specializing in power electronics based on gallium nitride technology designed to miniaturize power supplies and improve energy efficiency. The company's product can be used in chargers, power supplies for e-mobility, industrial applications, personal computer chargers, and data centers as well as offers efficiency and high-power-density alternating current and direct current converters and reliability for better usage, enabling clients to optimize system integration with reduced cost and size.

Unseenlabs

Series C in 2024
Unseenlabs is a French company based in Rennes, founded in 2015, that specializes in marine surveillance services utilizing satellite technology. The company develops spectrum surveillance payloads that enable the detection and tracking of non-cooperative vessels globally. By launching satellites equipped to detect and geolocate signals and electromagnetic waves emitted by ships, Unseenlabs can identify vessels even if they disable their Automatic Identification System beacon. This capability allows clients to monitor maritime activities and locate boats engaged in illegal operations, such as illegal fishing, degassing, and maritime piracy. Unseenlabs provides comprehensive solutions that encompass satellite design and launch, ensuring effective maritime monitoring from space.

Cambridge Mechatronics

Venture Round in 2024
Cambridge Mechatronics Ltd. is a technology design and engineering company based in Cambridge, United Kingdom, specializing in the development of mechatronic systems for mobile phone and consumer electronics markets. Founded in 1995, the company focuses on creating innovative products using Shape Memory Alloy actuators, which enable functionalities such as optical image stabilization and high-resolution autofocus in smartphone cameras. In addition to camera systems, Cambridge Mechatronics produces Dynasonix 3D audio products and Digital Sound Projectors, which direct sound beams to enhance audio experiences. The company has developed a significant intellectual property portfolio, including over 100 granted patents, and collaborates with global manufacturing partners to bring its cutting-edge technologies from concept to mass production.

Vulkam

Venture Round in 2023
Vulkam SAS is a microtechnology company based in Saint-Martin-d'Hères, France, that specializes in the design, development, and production of amorphous metal parts. Founded in 2017, Vulkam utilizes biocompatible amorphous metal alloys primarily composed of materials such as zirconium, copper, hafnium, nickel, and titanium. The company's innovative products find applications across various industries, including aerospace, automotive, biomedical, cryogenic, watches, jewellery, and micro components. Vulkam's focus on creating micromechanical parts that are significantly smaller yet maintain strength and functionality sets a new standard in metallurgy and metal processing, positioning the company as a leader in the development of advanced metal technologies.

Carthera

Series B in 2023
CarThera is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices aimed at treating brain disorders. The company has created the SonoCloud®, an intracranial ultrasound implant that works in conjunction with a microbubble agent administered intravenously. This combination temporarily opens the blood-brain barrier, allowing for a significantly increased concentration of therapeutic molecules to penetrate the brain. By enhancing the delivery of treatments, CarThera's technology offers potential solutions for debilitating neurological conditions, providing healthcare professionals with new avenues for patient care.

Adionics

Series B in 2023
Adionics is a technology provider based in Paris, France, specializing in saline water treatment and desalination supply chains. Founded in 2012, the company focuses on developing innovative technologies for the selective extraction of salts from brine, seawater, and other salty waters. Its AquaOmnes technology effectively removes salt from water, while Flionex is an ion-absorbing liquid technology designed to bind salts, including lithium. Adionics serves various industries, including municipal water, power, oil and gas, and chemicals. The company is also engaged in research and development to enhance its processes and enable lithium recycling from batteries, aiming to provide efficient and environmentally friendly solutions for extracting valuable minerals.

EODev

Series A in 2023
EODev is focused on accelerating the energy transition through the development of sustainable and efficient industrial solutions. The company specializes in hydrogen generation technology, providing a range of products and services that include energy design, hydrogen generators, and navigation range extenders. By offering innovative renewable hydrogen products, EODev enables various energy sectors to access clean and sustainable energy alternatives to fossil fuels, thereby contributing to a more environmentally friendly energy landscape.

Aledia

Venture Round in 2023
Aledia SA specializes in the development and manufacturing of innovative light-emitting diodes (LEDs) utilizing a unique 3D architecture based on gallium-nitride-on-silicon microwires. Founded in 2011 and headquartered in Grenoble, France, with additional subsidiaries in Malacca, Malaysia, and Palo Alto, California, Aledia's technology employs standard 8-inch silicon wafers and existing fabrication processes, allowing for the production of LED chips at a significantly reduced cost compared to traditional planar designs. This technology supports a range of applications, including general lighting, automotive, and display technologies, specifically for mobile and microdisplays used in augmented and virtual reality environments. Aledia's focus on efficient, brighter, and cost-effective displays positions it as a key player in the LED market.

Quobly

Seed Round in 2023
Quobly specializes in the development and marketing of a universal large-scale quantum computer, leveraging established semiconductor industry techniques. The company focuses on creating quantum computing semiconductors designed for commercial applications, enabling clients to utilize quantum computers for various complex problems. These applications include optimizing energy distribution and accelerating drug development by computing chemical properties more efficiently. Quobly aims to meet the specific needs of its clients by providing reliable and effective quantum computing solutions based on proven semiconductor processes.

Allotex

Series B in 2023
Allotex, Inc. is an ophthalmic biologics and device company based in Boston, Massachusetts, established in 2013. The company specializes in developing innovative contact lenses and therapeutic solutions aimed at addressing refractive vision issues, including presbyopia, hyperopia, and myopia. Allotex utilizes precisely-shaped human corneal allografts in conjunction with a compact excimer laser system to create permanent, living contact lenses or lens inserts. This approach enables medical professionals to provide minimally invasive treatment options for various refractive procedures, enhancing patient outcomes in vision correction.

Gleamer

Series B in 2023
Gleamer is a company specializing in artificial intelligence-based solutions for radiology, focusing on enhancing diagnostic accuracy for medical imaging. By integrating its AI companions into the existing reading environments of radiologists, Gleamer provides an automated second reading that aids in the detection of bone abnormalities, lesions, and other critical details in X-ray images. This technology not only improves efficiency but also helps ensure that all patients receive accurate diagnoses. Currently, Gleamer's solutions are utilized in over 300 institutions across 13 countries, demonstrating its commitment to advancing radiological practices and supporting medical professionals in prioritizing patient care.

Carthera

Series B in 2023
CarThera is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices aimed at treating brain disorders. The company has created the SonoCloud®, an intracranial ultrasound implant that works in conjunction with a microbubble agent administered intravenously. This combination temporarily opens the blood-brain barrier, allowing for a significantly increased concentration of therapeutic molecules to penetrate the brain. By enhancing the delivery of treatments, CarThera's technology offers potential solutions for debilitating neurological conditions, providing healthcare professionals with new avenues for patient care.

BeFC Bioenzymatic Fuel Cells

Series A in 2023
BeFC Bioenzymatic Fuel Cells is a company based in Grenoble, France, founded in 2020, that specializes in developing eco-friendly energy solutions. The company focuses on creating paper-based, ultra-thin, flexible, and miniature bioenzymatic fuel cell systems designed for sustainable energy generation. These innovative devices provide a safer alternative to traditional button or coin cell batteries, which are often difficult to recycle and environmentally harmful. BeFC's technology aims to address the growing need for sustainable power sources in disposable medical and wearable devices, facilitating the advancement of single-use applications while minimizing ecological impact. Additionally, its fuel cells present new opportunities for low-power applications in health monitoring, logistics, and the Internet of Things (IoT).

ProovStation

Series A in 2023
ProovStation is a DeepTech start-up operating in 13 European countries that focuses on automating and standardizing the automotive inspection process through advanced computer vision technology. Since its inception in 2017, the company has aimed to enhance the efficiency of vehicle inspections and reduce associated costs. ProovStation develops high-tech vehicle scanners that utilize a combination of optical technologies to perform a complete 360° scan of vehicles in just three seconds, analyzing damages at a millimeter scale. The integrated artificial intelligence system detects, measures, and locates all damages, generating a secure, time-stamped, and geolocated report. In addition to inspection services, ProovStation offers a suite of Software as a Service (SaaS) solutions, including automatic reconditioning quotes, vehicle pricing for resale, and activity management tools, enhancing the overall customer and employee experience in the automotive sector.

SoniVie

Series C in 2023
SoniVie is engaged in the development of a medical device aimed at treating pulmonary hypertension through advanced denervation techniques. The company’s device involves a catheter that is inserted into the pulmonary artery during a minimally invasive procedure. This device selectively targets and damages the nerves linked to the disease without affecting the vessel walls or surrounding tissues, allowing physicians to effectively address the condition.

Remedee Labs

Series A in 2022
Remedee Labs SAS is a French company founded in 2016, specializing in the research and development of a personal endorphin stimulator aimed at pain management. The company has created the Microelectronic Endorphin Trigger (MEET), a device designed to stimulate the release of the body’s own endorphins on demand. This innovative technology is particularly focused on helping individuals suffering from chronic pain conditions, with an initial emphasis on fibromyalgia. Remedee Labs has developed a patient-centered digital service platform that collaborates with medical practitioners to enhance chronic pain management. Backed by a decade of pre-clinical and clinical research, the company aims to provide a new approach to pain relief for the 1.5 billion people worldwide affected by chronic pain, many of whom are dissatisfied with existing treatment options. In 2019, Remedee Labs secured significant funding from various investors to further its mission of making endorphin-stimulation therapy accessible and effective for personal healthcare.

Aniah

Series A in 2022
Aniah specializes in providing an integrated circuit (IC) verification tool designed to identify and rectify electrical errors in chip designs efficiently. The company's platform conducts a comprehensive analysis at the transistor level, ensuring that all potential power states are covered in a single run. This approach allows users to concentrate on genuine errors rather than sifting through false positives. Aniah's technology delivers relevant results within seconds, empowering engineers to enhance their designs continuously and expedite the sign-off process. By minimizing the risk of electrical errors early in the design phase, Aniah supports semiconductor projects and improves overall workflow efficiency for its clients.

CrowdSec

Series A in 2022
CrowdSec is an open-source cybersecurity platform that analyzes the behavior of internet protocol addresses to detect and respond to various types of attacks. The software provides real-time threat detection and security automation, helping to prevent data breaches and enhance overall internet safety. By leveraging the collective intelligence of its user community, CrowdSec informs members whenever an IP address is blocked, fostering a collaborative approach to cybersecurity. This community-driven model aims to make the internet a safer environment for all users.

Prophesee

Series C in 2022
Prophesee SA, founded in 2014 and based in Paris, France, specializes in advanced machine vision sensors and systems through its innovative neuromorphic vision technology. Originally known as Chronocam SAS, the company rebranded in 2018 to reflect its pioneering approach to computer vision, which mimics the human eye and brain by detecting essential motion information rather than capturing a series of images. This unique Metavision® method enables Prophesee to achieve exceptional performance metrics, including high-speed time resolution, dynamic range, and significant reductions in data volume and power consumption. Its technology caters to a diverse range of industries, including biomedical, gaming, industrial automation, mobile devices, robotics, security, and automotive applications. Prophesee's team of over 100 engineers holds more than 50 international patents and has established a global presence with offices in cities such as Grenoble, Shanghai, Tokyo, and Silicon Valley, supported by a network of prominent investors.

Moments Lab

Series A in 2022
Moments Lab is a media valorization platform focused on enhancing the efficiency of content creation for various media professionals, including TV networks, sports rights holders, production companies, and journalists. The platform utilizes MXT Multimodal AI to address video indexing challenges, allowing users to make audiovisual content searchable and enabling quicker access to key moments for storytelling. Moments Lab offers several solutions, including Just Index for metadata extraction, Media Hub for advanced media asset management, Live Asset Manager for real-time access to live streams, and Media Marketplace for monetizing media libraries. By improving productivity and reducing the time needed to build video stories, Moments Lab empowers its clients to better manage live recordings, clip highlights, and license content. The platform aims to provide immediate returns on investment by increasing the reusability and discoverability of content across various search engine platforms. Clients include notable organizations such as Hearst Corporation, Agence France Presse, and the French Football Federation, illustrating the platform's global reach and impact on the media industry.

Micropep

Series A in 2022
Micropep Technologies is an agricultural biotechnology firm based in Toulouse, France, founded in 2016. The company specializes in developing non-GMO bioherbicides and biostimulants through its proprietary miPEP technology, which utilizes naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep's approach allows for the temporary control of gene expression without altering the plant's DNA, focusing on optimizing various stages of plant development, including germination, flowering, growth, and weed control. By leveraging these innovative solutions, Micropep aims to improve agricultural yields and support sustainable farming practices.

Scintil Photonics

Venture Round in 2022
Scintil Photonics SAS, founded in 2018 and based in Grenoble, France, specializes in the development of silicon photonic integrated circuits aimed at advancing high-speed optical communications and chip interconnections. The company offers a range of products, including multi-wavelength lasers, waveguides, wavelength filters, and photodetectors. By employing wafer-scale bonding techniques that combine Silicon and Indium Phosphide materials, Scintil Photonics creates fully integrated circuits that enhance performance and reliability while significantly lowering implementation costs. Their innovative approach allows for the monolithic integration of optical amplifiers and lasers on advanced silicon photonic circuits, making their solutions suitable for a variety of industrial applications.

Diabeloop

Series C in 2022
Diabeloop is a medical device company based in Grenoble, France, focused on innovating diabetes treatment through advanced technology. Founded in 2015, the company specializes in developing an AI-based closed-loop system that automates insulin delivery for individuals with type 1 diabetes. This system includes a blood sugar monitoring device that combines a glucose sensor, an insulin pump, and a smartphone application featuring an embedded algorithm. By continuously measuring glucose levels and delivering the appropriate insulin dosage, Diabeloop aims to reduce the mental burden on patients, allowing them to manage their condition more effectively and live their lives with greater ease.

UnitySC

Venture Round in 2022
UnitySC is a globally recognized leader in inspection and metrology, specializing in advanced technologies such as automated optical inspection and 3D imaging. By offering customized solutions tailored to specific industrial requirements, UnitySC empowers customers to enhance yields and accelerate time to market. Through innovative techniques like high depth of focus line scanning and spectrometry, UnitySC enables a new era in process control, facilitating efficient and precise manufacturing operations.

Cairdac

Series A in 2022
Cairdac is a medtech startup focused on developing an innovative leadless pacing system that utilizes a self-sustaining power technology. The company has achieved a significant milestone by creating the first self-sustaining pacemaker with a lifespan exceeding 15 years, leveraging a proprietary piezoelectric energy harvester in conjunction with a miniaturized power management circuit. Their unique product, the ALPS, is an autonomous and endoscopically implanted leadless pacemaker designed to harness the heart's kinetic energy for power. By integrating disruptive technologies into traditional pacemaker designs, Cairdac aims to provide a cost-effective solution that addresses the evolving needs of patients and healthcare professionals while enhancing the overall quality of life for those requiring cardiac rhythm management.

Terakalis

Series A in 2022
Terakalis is a company that specializes in the development of non-destructive testing equipment focused on material analysis and industrial process control. Established through a technological partnership in 2012 with the Charles Coulomb laboratory, Terakalis harnesses TeraHertz electromagnetic waves for its innovative solutions. The company offers a range of both generic and custom-made products designed to inspect internal defects and assess the physical and chemical properties of materials. By providing integrated line-of-production systems and portable alternatives, Terakalis enables businesses to enhance their operational efficiency and quality assurance in various industrial applications.

Alice & Bob

Series A in 2022
Alice & Bob is a Paris-based company founded in 2020 that specializes in the manufacture of universal, error-free quantum computers. The company's innovative technology features self-correcting superconducting quantum bits, which allow for fault-tolerant quantum computing. This capability enables the execution of any quantum algorithm, thereby assisting industries and researchers in addressing complex challenges across various fields. By focusing on developing advanced quantum computing solutions, Alice & Bob aims to facilitate breakthroughs in solving significant problems in quantum research and industry applications.

Aleph Zero

Seed Round in 2022
Aleph Zero is a developer of a peer-reviewed distributed ledger platform designed to address the limitations of existing blockchain infrastructures across various industries. The platform utilizes a proof-of-stake consensus mechanism and features a directed acyclic graph (DAG) architecture, ensuring high speed and scalability. Aleph Zero incorporates privacy-enhancing capabilities based on secure multi-party computation research, allowing developers to innovate without technological constraints. Its ecosystem supports smart contracts and includes a universally trustless wallet, facilitating seamless interactions with other blockchains. The company aims to promote the mass adoption of distributed ledger technology through its advanced and developer-friendly offerings.

Traxens

Venture Round in 2022
Traxens is a provider of supply chain tracking services that offers comprehensive data and analytics to enhance visibility into container transport and logistics. The company focuses on delivering precise and timely information on containers and their transporters, enabling stakeholders in multi-modal transport to improve operational efficiency, reduce costs, and optimize investments. Through a dedicated three-year research and development program, Traxens has developed advanced technology for cost-effective, durable, and autonomous devices capable of capturing and transmitting real-time data from anywhere in the world. This innovative approach allows Traxens to transform logistics data into actionable insights, benefiting a wide range of customers in the supply chain industry.

NAWA Technologies

Series C in 2022
NAWA Technologies specializes in developing advanced energy storage solutions, focusing on its innovative Ultra Fast Carbon Battery Technology. Founded in April 2013 and supported by over 15 years of research and development in nanomaterials, the company aims to enhance energy conversion, storage, transport, and efficiency using carbon, which is abundant and environmentally friendly. NAWA Technologies creates ultracapacitors and battery electrodes that facilitate the integration of renewable energies into smart grids, thus promoting more efficient and sustainable electricity storage. The company is committed to minimizing the environmental impact of its manufacturing processes and emphasizes the importance of reusing, recovering, and recycling materials throughout the product lifecycle. With a dedicated team of 24 employees, NAWA Technologies operates a pilot production line to innovate new interface materials and storage devices that reduce carbon emissions and reliance on fossil fuels.

iFollow

Series A in 2021
iFollow specializes in the development of collaborative autonomous robots aimed at enhancing efficiency in the logistics and retail industries. The company manufactures autonomous mobile robots (AMRs) designed to automate the transportation of heavy loads within industrial settings. In addition to its robotics, iFollow offers a proprietary software suite that supports various applications across multiple sectors, including food, pharmaceuticals, chemicals, cosmetics, and logistics. By leveraging their technology, iFollow helps clients optimize their intralogistics processes, ultimately increasing productivity and streamlining operations.

CORE for Tech

Venture Round in 2021
Core for Tech is a deep technology company focused on enhancing driver safety by measuring and predicting drowsiness while driving. Utilizing advanced technology that analyzes heart rate variability through native sensors or retrofit systems in vehicles, Core for Tech transforms this data into actionable insights about a driver's fatigue levels. By detecting drowsiness at an early stage, before it becomes visibly apparent, the company aims to provide timely information that enables drivers to make informed safety decisions. Through its innovative approach, Core for Tech seeks to contribute significantly to road safety and reduce the risks associated with driver fatigue.

Micropep

Series A in 2021
Micropep Technologies is an agricultural biotechnology firm based in Toulouse, France, founded in 2016. The company specializes in developing non-GMO bioherbicides and biostimulants through its proprietary miPEP technology, which utilizes naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep's approach allows for the temporary control of gene expression without altering the plant's DNA, focusing on optimizing various stages of plant development, including germination, flowering, growth, and weed control. By leveraging these innovative solutions, Micropep aims to improve agricultural yields and support sustainable farming practices.

Adionics

Seed Round in 2021
Adionics is a technology provider based in Paris, France, specializing in saline water treatment and desalination supply chains. Founded in 2012, the company focuses on developing innovative technologies for the selective extraction of salts from brine, seawater, and other salty waters. Its AquaOmnes technology effectively removes salt from water, while Flionex is an ion-absorbing liquid technology designed to bind salts, including lithium. Adionics serves various industries, including municipal water, power, oil and gas, and chemicals. The company is also engaged in research and development to enhance its processes and enable lithium recycling from batteries, aiming to provide efficient and environmentally friendly solutions for extracting valuable minerals.

Dessia

Series A in 2021
DessIA is a developer of augmented engineering software that leverages artificial intelligence to streamline product development. The company's platform assists engineers and architects by automating tasks in the early stages of design, generating numerous architectural options, and identifying optimal configurations that align with sustainability and profitability goals. By addressing complex engineering challenges, DessIA enables automotive and mechanical engineers to enhance their efficiency and explore innovative solutions, ultimately reducing lead times and increasing profit margins.

Smartway

Series A in 2021
Smartway, founded in 2012 by two brothers, focuses on reducing food and non-food waste while helping consumers save money. The company developed a food waste management platform that utilizes artificial intelligence to assist in-store teams in identifying products nearing their expiry dates. Smartway facilitates the sale of these items at discounted prices and streamlines the donation process for unsold goods, enhancing operational efficiency for supermarkets. By creating a connection between consumers and distributors, Smartway offers a free service that lists nearby products available for quick consumption, benefiting both consumers and retailers. The company has garnered recognition for its contributions to sustainable development and is expanding its presence across Europe.

Zéro-Gâchis

Venture Round in 2021
Zéro-Gâchis is an innovative service to save money and avoid food waste during your shopping. The objective of Zéro-Gâchis is to reduce food waste by assisting retailers in managing unsold items. Enabling everyone to take action to reduce food waste naturally brings forth strong values that drive the team's manner of working and its constant desire to improve service efficiency.

UroMems

Series B in 2021
UroMems is a company dedicated to addressing specific clinical needs related to patient care, particularly in the area of urology. It develops implantable medical devices aimed at enhancing existing surgical treatments, thereby improving patient outcomes and reducing side effects. By focusing on innovative solutions, UroMems seeks to ensure that more patients can access effective treatments quickly, ultimately aiming to enhance their quality of life. The company is committed to the design, development, and commercialization of these active implantable devices, which reflect a deep understanding of the challenges faced by patients.

AcuSurgical

Series A in 2021
AcuSurgical is a startup focused on advancing vitreo-retinal surgery through the development of a robotic surgical assistant. This innovative device is designed to enhance the precision and effectiveness of eye operations, particularly for treating retinal diseases like age-related macular degeneration. By providing surgeons with advanced tools to filter tremors and improve visualization during procedures, AcuSurgical aims to improve outcomes and increase the success rates of retinal surgeries.

PowerUp

Venture Round in 2020
PowerUp Technology specializes in designing and marketing battery management and optimization solutions for various sectors, including fleet management and consumer applications. Founded in 2017 and based in Aulnay-Sous-Bois, France, the company offers smart chargers that adapt charging conditions based on battery temperature, charge status, and degradation levels. Its innovative solutions provide real-time measurements of battery health, optimize charging processes, and enable efficient management of battery fleets through a web application. PowerUp's technology is applicable across diverse industries such as railways, backup battery systems, portable tools, personal vehicles, and consumer electronics. By focusing on the economic and ecological costs of battery usage, PowerUp aids businesses in monitoring battery health throughout their lifecycle, facilitating predictive maintenance and extending battery longevity.

Ynsect

Series C in 2020
Ynsect is a biotechnology company based in Evry, France, that specializes in the production and processing of insects for sustainable animal feed and non-food applications. Founded in 2011, Ynsect operates insect vertical farms that convert insects into high-quality nutrition products, including proteins and lipids for livestock and pet diets. The company employs innovative bioconversion techniques to utilize organic resources, producing not only animal feed but also organic fertilizers, bioenergy, and other valuable materials. Ynsect's expertise in large-scale insect farming and automation has positioned it as a leading provider in the agro-food and environmental biotech sectors, making it a favored partner for agricultural professionals, research institutions, and investors.

Microoled

Series A in 2020
Microoled is a French company specializing in the development and manufacturing of microdisplays for mobile near-to-eye viewing devices. Established in 2007 and headquartered in Grenoble, the company focuses on creating AMOLED displays and optical modules that cater to various sectors, including consumer electronics, medical applications, and security. Microoled's product range encompasses video glasses, head-mounted sports devices, and camera viewfinders, among other professional equipment. By addressing customer needs and anticipating market demands, Microoled aims to enhance user experiences across diverse applications.

BeFC Bioenzymatic Fuel Cells

Seed Round in 2020
BeFC Bioenzymatic Fuel Cells is a company based in Grenoble, France, founded in 2020, that specializes in developing eco-friendly energy solutions. The company focuses on creating paper-based, ultra-thin, flexible, and miniature bioenzymatic fuel cell systems designed for sustainable energy generation. These innovative devices provide a safer alternative to traditional button or coin cell batteries, which are often difficult to recycle and environmentally harmful. BeFC's technology aims to address the growing need for sustainable power sources in disposable medical and wearable devices, facilitating the advancement of single-use applications while minimizing ecological impact. Additionally, its fuel cells present new opportunities for low-power applications in health monitoring, logistics, and the Internet of Things (IoT).

UroMems

Series B in 2020
UroMems is a company dedicated to addressing specific clinical needs related to patient care, particularly in the area of urology. It develops implantable medical devices aimed at enhancing existing surgical treatments, thereby improving patient outcomes and reducing side effects. By focusing on innovative solutions, UroMems seeks to ensure that more patients can access effective treatments quickly, ultimately aiming to enhance their quality of life. The company is committed to the design, development, and commercialization of these active implantable devices, which reflect a deep understanding of the challenges faced by patients.

NAWA Technologies

Venture Round in 2020
NAWA Technologies specializes in developing advanced energy storage solutions, focusing on its innovative Ultra Fast Carbon Battery Technology. Founded in April 2013 and supported by over 15 years of research and development in nanomaterials, the company aims to enhance energy conversion, storage, transport, and efficiency using carbon, which is abundant and environmentally friendly. NAWA Technologies creates ultracapacitors and battery electrodes that facilitate the integration of renewable energies into smart grids, thus promoting more efficient and sustainable electricity storage. The company is committed to minimizing the environmental impact of its manufacturing processes and emphasizes the importance of reusing, recovering, and recycling materials throughout the product lifecycle. With a dedicated team of 24 employees, NAWA Technologies operates a pilot production line to innovate new interface materials and storage devices that reduce carbon emissions and reliance on fossil fuels.

Vulkam

Series A in 2020
Vulkam SAS is a microtechnology company based in Saint-Martin-d'Hères, France, that specializes in the design, development, and production of amorphous metal parts. Founded in 2017, Vulkam utilizes biocompatible amorphous metal alloys primarily composed of materials such as zirconium, copper, hafnium, nickel, and titanium. The company's innovative products find applications across various industries, including aerospace, automotive, biomedical, cryogenic, watches, jewellery, and micro components. Vulkam's focus on creating micromechanical parts that are significantly smaller yet maintain strength and functionality sets a new standard in metallurgy and metal processing, positioning the company as a leader in the development of advanced metal technologies.

Diabeloop

Series B in 2019
Diabeloop is a medical device company based in Grenoble, France, focused on innovating diabetes treatment through advanced technology. Founded in 2015, the company specializes in developing an AI-based closed-loop system that automates insulin delivery for individuals with type 1 diabetes. This system includes a blood sugar monitoring device that combines a glucose sensor, an insulin pump, and a smartphone application featuring an embedded algorithm. By continuously measuring glucose levels and delivering the appropriate insulin dosage, Diabeloop aims to reduce the mental burden on patients, allowing them to manage their condition more effectively and live their lives with greater ease.

Remedee Labs

Series A in 2019
Remedee Labs SAS is a French company founded in 2016, specializing in the research and development of a personal endorphin stimulator aimed at pain management. The company has created the Microelectronic Endorphin Trigger (MEET), a device designed to stimulate the release of the body’s own endorphins on demand. This innovative technology is particularly focused on helping individuals suffering from chronic pain conditions, with an initial emphasis on fibromyalgia. Remedee Labs has developed a patient-centered digital service platform that collaborates with medical practitioners to enhance chronic pain management. Backed by a decade of pre-clinical and clinical research, the company aims to provide a new approach to pain relief for the 1.5 billion people worldwide affected by chronic pain, many of whom are dissatisfied with existing treatment options. In 2019, Remedee Labs secured significant funding from various investors to further its mission of making endorphin-stimulation therapy accessible and effective for personal healthcare.

Cailabs

Series B in 2019
Cailabs is a French deep tech company based in Rennes, specializing in the design and production of photonic solutions that optimize the use of light in various applications. The company focuses on light shaping components, including mode multiplexers and converters for fiber optic networks, utilizing its patented Multi-Plane Light Conversion (MPLC) technology to reshape both single-mode and multi-mode coherent beams. Cailabs offers products tailored for telecommunications research and development, as well as multi-mode fiber link upgrades for enterprise networks. Additionally, the company provides integrated solutions for the industrial laser sector, such as laser beam shapers and combiners for material processing, and mode-selective multiplexers for EDFA arrays. Founded in 2013, Cailabs aims to address critical industrial challenges through its innovative optical components and expertise.

Scintil Photonics

Seed Round in 2019
Scintil Photonics SAS, founded in 2018 and based in Grenoble, France, specializes in the development of silicon photonic integrated circuits aimed at advancing high-speed optical communications and chip interconnections. The company offers a range of products, including multi-wavelength lasers, waveguides, wavelength filters, and photodetectors. By employing wafer-scale bonding techniques that combine Silicon and Indium Phosphide materials, Scintil Photonics creates fully integrated circuits that enhance performance and reliability while significantly lowering implementation costs. Their innovative approach allows for the monolithic integration of optical amplifiers and lasers on advanced silicon photonic circuits, making their solutions suitable for a variety of industrial applications.

Keranova

Venture Round in 2019
Keranova S.A., founded in 2015 and based in Saint Etienne, France, along with an office in Vénissieux, specializes in designing and developing innovative surgical equipment for ophthalmology, specifically targeting the anterior segment of the eye. The company focuses on creating advanced surgical instruments that aim to enhance existing semi-manual, operator-dependent procedures in ophthalmic surgery. Keranova's patented technology allows for a novel approach to anterior segment surgery, utilizing automated equipment equipped with vision, intelligent software, and precise robotic movements. This innovation significantly reduces the need for manual intervention, thereby improving the reproducibility and efficiency of surgical procedures.

Robocath

Venture Round in 2019
Robocath, founded in 2009 by Philippe Bencteux, MD, specializes in designing, developing, and commercializing robotic solutions for treating cardiovascular diseases. The company focuses on enhancing the safety and effectiveness of medical procedures through innovative robotic technology. Its flagship product, R-One™, optimizes the safety of robotic-assisted coronary angioplasty, a procedure aimed at revascularizing the cardiac muscle by inserting implants into arteries. R-One™ is engineered for precision and specific movements, improving interventional conditions for surgeons while minimizing their exposure to x-rays. With an open architecture, it is compatible with leading medical devices and catheterization laboratories. Robocath aims to become a global leader in vascular robotics, particularly in the remote treatment of vascular emergencies, ensuring optimal care pathways for patients.

Traxens

Series C in 2019
Traxens is a provider of supply chain tracking services that offers comprehensive data and analytics to enhance visibility into container transport and logistics. The company focuses on delivering precise and timely information on containers and their transporters, enabling stakeholders in multi-modal transport to improve operational efficiency, reduce costs, and optimize investments. Through a dedicated three-year research and development program, Traxens has developed advanced technology for cost-effective, durable, and autonomous devices capable of capturing and transmitting real-time data from anywhere in the world. This innovative approach allows Traxens to transform logistics data into actionable insights, benefiting a wide range of customers in the supply chain industry.

Microphyt

Venture Round in 2019
Microphyt specializes in the research, development, production, and marketing of natural algae-based products aimed at enhancing health and wellness. The company focuses on creating bioactive dietary supplements that support weight loss and brain health. Utilizing an industrial-scale supply of microalgae biomass and extracts, Microphyt ensures the preservation of cell integrity while producing commercial quantities of slow-growing or biofilm-forming species. This approach enables the healthcare industry to effectively meet the demands of personal care and food products, positioning Microphyt as a key player in the market for natural health solutions.

NAWA Technologies

Venture Round in 2019
NAWA Technologies specializes in developing advanced energy storage solutions, focusing on its innovative Ultra Fast Carbon Battery Technology. Founded in April 2013 and supported by over 15 years of research and development in nanomaterials, the company aims to enhance energy conversion, storage, transport, and efficiency using carbon, which is abundant and environmentally friendly. NAWA Technologies creates ultracapacitors and battery electrodes that facilitate the integration of renewable energies into smart grids, thus promoting more efficient and sustainable electricity storage. The company is committed to minimizing the environmental impact of its manufacturing processes and emphasizes the importance of reusing, recovering, and recycling materials throughout the product lifecycle. With a dedicated team of 24 employees, NAWA Technologies operates a pilot production line to innovate new interface materials and storage devices that reduce carbon emissions and reliance on fossil fuels.

NH TherAguix

Series A in 2019
NH TherAguix SAS is a clinical stage pharmaceutical company based in Villeurbanne, France, focused on developing nanomedicines for cancer treatment, specifically utilizing radiotherapy. The company's lead product, AGuIX, is a theranostic nanoparticle designed to enhance the localization of solid tumors and improve the effectiveness of radiation therapy. AGuIX allows for the determination of optimal irradiation timing and is capable of treating radioresistant cancers while minimizing radiation exposure to healthy tissues, thereby reducing secondary effects. Founded in 2015, NH TherAguix is dedicated to advancing innovative solutions in cancer care through its pioneering research and development efforts.

Diota

Series B in 2019
Diota specializes in developing augmented reality (AR) software solutions aimed at enhancing industrial processes and products. The company's flagship product, DiotaPlayer, seamlessly integrates with existing software and hardware systems to facilitate various industrial applications such as manufacturing, maintenance, product design, and training. Diota's AR solutions enable users to browse, interact, check, report, and track data effectively, leveraging devices like tablets and head-mounted displays. Founded in 2009 and based in Massy, France, Diota serves a diverse range of industries, including aerospace, automotive, and energy, with notable clients like Safran Group and Renault. In addition to software, Diota provides consulting, technical support, and training services, reinforcing its commitment to improving operational efficiency and competitiveness in the digital factory landscape across Europe.

Carthera

Series B in 2018
CarThera is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices aimed at treating brain disorders. The company has created the SonoCloud®, an intracranial ultrasound implant that works in conjunction with a microbubble agent administered intravenously. This combination temporarily opens the blood-brain barrier, allowing for a significantly increased concentration of therapeutic molecules to penetrate the brain. By enhancing the delivery of treatments, CarThera's technology offers potential solutions for debilitating neurological conditions, providing healthcare professionals with new avenues for patient care.

Blue Valet

Venture Round in 2018
Blue Valet is a French company founded in 2015, based in Mérignac, that specializes in online valet parking services for airports and train stations. The company offers a user-friendly platform that allows travelers to conveniently book valet parking, providing a stress-free and economical solution for both leisure and business customers. By catering to major mobility hubs, Blue Valet aims to enhance the travel experience, ensuring that clients can access their destinations without hassle.

iskn

Venture Round in 2018
iskn is a consumer electronics company that develops and markets the slate for smart drawing. iskn is the leading pioneer in AUGMENTED INTERACTION thanks to its technology representing 24 international patents based on 60 years of deep tech R&D expertise in magnetometry at the world-renowned CEA LETI. The company’s primary mission consists in enriching the experience and facilitate interaction with the digital world by bringing back emotion through the use of day-to-day physical objects. This has already come to life by turning any pencil into a digital one with the widely adopted SLATE, and the yet to come disruptive REPAPER graphic tablet.

Terakalis

Seed Round in 2018
Terakalis is a company that specializes in the development of non-destructive testing equipment focused on material analysis and industrial process control. Established through a technological partnership in 2012 with the Charles Coulomb laboratory, Terakalis harnesses TeraHertz electromagnetic waves for its innovative solutions. The company offers a range of both generic and custom-made products designed to inspect internal defects and assess the physical and chemical properties of materials. By providing integrated line-of-production systems and portable alternatives, Terakalis enables businesses to enhance their operational efficiency and quality assurance in various industrial applications.

Prophesee

Series B in 2018
Prophesee SA, founded in 2014 and based in Paris, France, specializes in advanced machine vision sensors and systems through its innovative neuromorphic vision technology. Originally known as Chronocam SAS, the company rebranded in 2018 to reflect its pioneering approach to computer vision, which mimics the human eye and brain by detecting essential motion information rather than capturing a series of images. This unique Metavision® method enables Prophesee to achieve exceptional performance metrics, including high-speed time resolution, dynamic range, and significant reductions in data volume and power consumption. Its technology caters to a diverse range of industries, including biomedical, gaming, industrial automation, mobile devices, robotics, security, and automotive applications. Prophesee's team of over 100 engineers holds more than 50 international patents and has established a global presence with offices in cities such as Grenoble, Shanghai, Tokyo, and Silicon Valley, supported by a network of prominent investors.

mirSense

Seed Round in 2018
mirSense SA is a developer and manufacturer of advanced Quantum Cascade Lasers (QCL) and QCL-based spectrometer modules, headquartered in Palaiseau, France. Established in 2015, the company specializes in ultra-compact gas sensors aimed at controlling gas emissions and analyzing biological samples. Its product lineup includes single mode lasers for high spectral purity, semiconductor solutions for broadband tuning, and spectrometer modules tailored for gas analyzer manufacturers. Additionally, mirSense produces power lasers for defense and security applications. The technology developed by mirSense is designed to achieve low detection levels, enhancing indoor and outdoor air quality, reducing greenhouse gas emissions, and improving the accuracy of medical treatments. By providing affordable high-performance laser spectroscopy alternatives, mirSense supports various industries in their pursuit of sustainability and safety.

En Voiture Simone

Venture Round in 2018
En Voiture Simone is an online driving school that facilitates the connection between learners and state-qualified driving instructors. Established in 2015, the platform allows students to find instructors tailored to their specific needs, promoting a personalized learning experience. By providing a convenient interface for discovering qualified teachers, En Voiture Simone aims to support individuals in their journey toward obtaining a driving license. The company focuses on making the driving education process more accessible and efficient for students.

Aledia

Series C in 2018
Aledia SA specializes in the development and manufacturing of innovative light-emitting diodes (LEDs) utilizing a unique 3D architecture based on gallium-nitride-on-silicon microwires. Founded in 2011 and headquartered in Grenoble, France, with additional subsidiaries in Malacca, Malaysia, and Palo Alto, California, Aledia's technology employs standard 8-inch silicon wafers and existing fabrication processes, allowing for the production of LED chips at a significantly reduced cost compared to traditional planar designs. This technology supports a range of applications, including general lighting, automotive, and display technologies, specifically for mobile and microdisplays used in augmented and virtual reality environments. Aledia's focus on efficient, brighter, and cost-effective displays positions it as a key player in the LED market.

UPMEM

Seed Round in 2017
UPMEM is a fabless semiconductor company focused on enhancing the performance of data-intensive algorithms through its innovative Processing-In-Memory (PIM) solution. This technology addresses the limitations of traditional server architectures, which are hindered by data movement inefficiencies. By deploying a large number of programmable co-processors close to the data, UPMEM's platform accelerates performance for analytics and artificial intelligence applications by more than ten times. This unique approach not only improves computational speed but also reduces energy consumption and hardware footprint in data centers, making it an attractive solution for major application developers and cloud service providers.

SeqOne Genomics

Healthcare is undergoing a revolution, known as genomic medicine, that uses the patient’s genomic information to optimise treatment. This trend is accelerating thanks to the arrival of New Generation Sequencing (NGS) techniques that have reduced the cost of decoding genomic material while increasing the amount useful data obtained. However, NGS has had only limited impact on mainstream healthcare due to the difficulties in analyzing more and richer genomic data. SeqOne’s mission is to provide tools that enable the healthcare industry to analyse NGS genomic data better and more cost-effectively to provide universal access to genomic medicine.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.